The upregulation of tRNA m7G methyltransferase complex components METTL1 and WD repeat domain 4 has enhanced lapatinib resistance in HCC and increased sensitivity to METTL1-targeting therapies (26). The gene discussed is METTL1; the disease is hepatocellular carcinoma.